Mizoshita, T., Tanida, S., Ozeki, K., Katano, T., Shimura, T., Mori, Y., . . . Joh, T. (2016). Long-Term Clinical Remission in Biologically Naïve Crohn's Disease Patients with Adalimumab Therapy, Including Analyses of Switch from Adalimumab to Infliximab. Case Rep Gastroenterol.
Dyfyniad Arddull ChicagoMizoshita, Tsutomu, et al. "Long-Term Clinical Remission in Biologically Naïve Crohn's Disease Patients With Adalimumab Therapy, Including Analyses of Switch From Adalimumab to Infliximab." Case Rep Gastroenterol 2016.
Dyfyniad MLAMizoshita, Tsutomu, et al. "Long-Term Clinical Remission in Biologically Naïve Crohn's Disease Patients With Adalimumab Therapy, Including Analyses of Switch From Adalimumab to Infliximab." Case Rep Gastroenterol 2016.